Disruption of glucose homeostasis increases the risk of type II diabetes, cardiovascular disease, stroke, 53 and cancer. We leverage a novel rodent model, the SM/J mouse, to understand glycemic control in 54 obesity. On a high fat diet, obese SM/J mice initially develop impaired glucose tolerance and elevated 55 fasting glucose. Strikingly, their glycemic dysfunction resolves by 30 weeks of age despite persistence of 56 obesity. A prominent phenotype is that they dramatically expand their brown adipose depots as they 57 resolve glycemic dysfunction. This occurs naturally and spontaneously on a high fat diet, with no 58 temperature or genetic manipulation. When the brown adipose depot is removed from normoglycemic 59 obese mice, fasting blood glucose and glucose tolerance revert to unhealthy levels, and animals become 60 insulin resistant. We identified 267 genes whose expression changes in the brown adipose when the 61 mice resolve their unhealthy glycemic parameters, and find the expanded tissue has a 'healthier' 62 expression profile of cytokines and extracellular matrix genes. We describe morphological, physiological, 63 and transcriptomic changes that occur during the unique brown adipose expansion and remission of 64 glycemic dysfunction in obese SM/J mice. Understanding this phenomenon in mice will open the door for 65 innovative therapies aimed at improving glycemic control in obesity.
2A-C). This has never been described in another mouse strain, and we do not observe the phenomenon 135 in the LG/J strain of mice on the same diets at any age (Supplemental Figure 2) . To understand whether 136 the tissue mass expansion is due to increased size of individual cells or to increased number of total 137 cells, we quantified adipocyte cell size and the mitotic index. There are no significant differences in 138 average cell size in high fat-fed mice between 20 and 30 weeks, or relative to low fat-fed controls 139 (Supplemental Figure 3A) . Mice on both diets undergo altered adipocyte area profiles between 20 and 140 30 weeks of age, however the low fat tissue develops a profile significantly trending towards larger 141 adipocytes at 30 weeks (p=6.4 -07 ) whereas the high fat tissue develops a profile significantly trending 142 towards smaller adipocytes at 30 weeks (p=2.2 -16 ) (Figure 2D and E) . This suggests that the expansion 143 of the brown adipose depot in high fat-fed mice is the result of increased proliferation of adipocytes, as 144 newer adipocytes are smaller due to less lipid accumulation. This is supported by quantification of brown 145 adipose cells stained positive for the mitotic marker phosphohistone H3, which trends towards a higher 146 mitotic index in the brown adipose of high fat-fed animals (Supplemental Figure 3B ).
147
Because obesity has been associated with structural and functional "whitening" of brown adipose 148 depots in rodents (11) (12) (13) (14) , we performed experiments to confirm that the tissue expansion in SM/J mice 
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4A-B). Further, expression of Tbx1, a marker specific for beige adipocytes (15), indicates that neither 154 brown nor white adipose is "beiging" (Supplementary Figure 4C) . Finally, there is no significant 155 difference in brown adipose tissue mitochondrial content between the diets or ages (Supplementary 156 Figure 4D ). There is no difference in core body temperature or circulating free fatty acids between high no change in levels between ages in the high fat-fed mice (Supplemental Figure 5C and D) . Thus, the 161 interscapular adipose depot in high fat-fed SM/J mice maintains a brown adipose identity after expansion 162 that is not dependent on whole-animal beiging, and is also not associated with altered thermogenesis. Since the brown adipose tissue expansion is unique to high fat-fed SM/J mice, we anticipated that 191 there would be corresponding unique transcriptomic changes in the brown adipose. Indeed, we identified 192 267 genes whose expression significantly and uniquely changes between 20 and 30 weeks of age in 193 high fat-fed SM/J brown adipose tissue (at a 5% FDR, out of 13,253 total genes expressed;
194 Supplemental Table 2 ). These expression changes occur when the mice resolve their glycemic 195 dysfunction and expand their brown adipose depots. These genes are not differentially expressed in 196 white adipose tissue taken from the same animals or in low fat-fed SM/J controls ( Figure 4A ).
197
Additionally, they are not differentially expressed in the LG/J strain of mouse, once again underscoring 198 the genetic basis of the phenomenon ( Supplemental Table 3 ).
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Over-representation analysis indicates these genes are enriched for those involved in cytokine-
200
cytokine receptor interactions (p=3.23e -06 ), signaling receptor activity (p = 5.70e -06 ), cell surface receptor 201 signaling (p=2.04e -07 ), and extracellular matrix components (p = 7.93 e -13 ) ( Figure 4B) . These are 202 intriguing results because brown adipose has been identified as a source of cytokines that influence 203 glucose homeostasis, and extracellular matrix changes are essential for tissue expansion, cellular 204 signaling, and regulation of growth factor bioavailability.
205
Several genes belonging to these biological categories have evidence for their involvement in 206 glucose homeostasis and change expression in a direction that is associated with improved metabolic 207 health in high fat-fed SM/J mice between 20 and 30 weeks of age ( Figure 4C ; Supplemental Table 2 ).
208
In particular, the direction of expression change reveals that the expansion of brown adipose is 209 associated with decreased expression of inflammatory (e.g. interleukin 7 receptor, Il7r) (16) and fibrotic Because variation in glucose homeostasis is complex and the result of many interacting genes,
231
we examined the co-expression profile of genes belonging to the enriched cytokine and extracellular 232 matrix (ECM) biological categories (Figure 4B and C) . We find that the co-expression profile of the 233 differentially expressed ECM and cytokine genes is significantly different between 20 and 30 week-old 234 high fat-fed animals (p=0.01). To determine if the co-expression profile of these genes in 30 week-old 235 high fat-fed animals' brown adipose is more similar to the 20 week-old high fat-fed or to the low fat-fed 236 animals', we compared the overall co-expression correlation structure between the diet and age cohorts 237 for these genes. Remarkably, we find the 30 week-old high fat-fed SM/J brown adipose ECM and cytokine 
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Greater understanding of the relationship between obesity and glycemic control is needed to develop 264 more effective preventative measures for obese patients.
265
Here we describe morphological, physiological, and transcriptomic changes that occur during 
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We identified 267 genes whose expression significantly and uniquely changes between 20 and 276 30 weeks of age in high fat-fed SM/J brown adipose tissue (Figure 5A) . We focus on genes associated 277 with ECM and cytokine activity because both biological categories are enriched in the set of genes that 278 significantly change expression in brown adipose during the remission of glycemic parameters. Brown adipose is a source of endocrine signals with anti-diabetic properties and is involved in extensive cross-280 talk with other organs (38). It secretes cytokines that influence whole-body glucose homeostasis and 281 insulin sensitivity including IGF1, FGF21, NRG-3 and NRG-4 (39). ECM changes are essential for cellular 282 signaling, regulation of growth factor bioavailability, and accompany healthy adipose expansion.
283
However, extreme changes in ECM protein levels are associated with adipose dysfunction in obesity;
284 thus a fine balance between tissue remodeling and excessive accumulation of ECM proteins must be 285 achieved to maintain adipose tissue homeostasis (18).
286
We highlight 8 cytokines and ECM genes that significantly change expression in a direction 287 associated with improved metabolic health in previous studies. Il7r, which was found to be one of the 288 highest ranking genes in the white adipose tissue inflammatory response pathway (40) 
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There is great interest in harnessing the potential of brown adipose to treat obesity and diabetes, 
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Animal health and well-being was monitored daily. Sutures were removed at 10 days post-surgery. Mice
469
were allowed to recover for four weeks after surgery or until they reached 30 weeks of age, then 470 underwent a glucose tolerance test and an insulin tolerance test one week later. After an additional week 471 of recovery, animals were sacrificed and plasma and multiple tissues harvested (reproductive and 472 inguinal adipose depots, liver, heart, soleus, pancreas, hypothalamus) as described above.
474
Statistics 475 Data within individual cohorts were assessed for normality using a Wilks-Shapiro test. Outliers 476 were identified by a Grubbs test (p < 0.05) and removed. Data were tested for significant differences 477 among cohorts by ANOVA with a Tukey's post-hoc correction. The sex X diet X age term was not 478 significant for any phenotype so males and females were pooled for analyses. P-values <0.05 were 479 considered significant. All statistical analyses were performed using the R software package.
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